The percentage and immunophenotype of CD66b+CD33dimHLA-DR-cells were analyzed in PBMCs from HL and B-cell NHL patients (n = 124) and healthy donors (n = 48). This evidence concerns the gene CEACAM8 and B-cell non-Hodgkin lymphoma.